EPW
MEDP icon

Evolve Private Wealth’s Medpace MEDP Stock Holding History

Evolve Private Wealth’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.39M Sell
2,618
-37
-1% -$17.1K 0.08% 211
2026
Q1 		$1.27M Sell
2,655
-1,070
-29% -$548K 0.07% 271
2025
Q4 		$2.09M Buy
+3,725
New +$2.11M 0.12% 152

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Evolve Private Wealth's MEDP Position: Q2 2026 in Review

Evolve Private Wealth reduced its Medpace (MEDP) stake by 1.4% in Q2 2026, selling an estimated $17.1K and leaving 2,618 shares worth $1.39M. The position accounts for 0.08% of the portfolio, ranked #211.

Evolve Private Wealth first reported a position in MEDP in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.09M in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Evolve Private Wealth held 2,618 shares of Medpace worth $1.39M as of Q2 2026.
  • Evolve Private Wealth sold 37 Medpace shares in Q2 2026, an estimated $17.1K.
  • Medpace made up 0.08% of Evolve Private Wealth's portfolio in Q2 2026, its #211 holding.
  • Evolve Private Wealth first reported a position in Medpace in Q4 2025 and has held it in 3 quarters since.
  • Evolve Private Wealth's Medpace position peaked at $2.09M in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Evolve Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.